Global Healthcare Nanotechnology Market Scope 2024, Forecast To 2033
20 Feb, 2024
The healthcare nanotechnology market has grown rapidly from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%. The historic growth is attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, and nanostructured biomaterials. Forecasts suggest continued rapid growth to $613.9 billion in 2028, boasting a CAGR of 14.9%. This growth is linked to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, and global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education, and therapeutic applications.
Global Healthcare Nanotechnology Market Key Driver
The healthcare nanotechnology market is expanding due to the increasing prevalence of cancer. Nanotechnology holds promise for cancer treatment, spurring research for personalized therapies. The United States is expected to witness 1,898,160 new cancer cases in 2021, emphasizing the critical role of healthcare nanotechnology in cancer care. The growing number of cancer cases is a significant factor driving the healthcare nanotechnology market.
Get A Free Sample Of The Global Healthcare Nanotechnology Market ReportGlobal Healthcare Nanotechnology Market Segments
The healthcare nanotechnology market covered in this report is segmented –
1)By Disease: Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases
2)By Type: Organic, Inorganic, Carbon-Based
3)By Application: Drug Delivery, Biomaterials, Active Implants, Tissue Regeneration
By Geography: The regions covered in the template market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the healthcare nanotechnology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Healthcare Nanotechnology Industry Players
Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Celgene Corporation; Merck & Company Inc.; Union Chimique Belge S. A; Teva Pharmaceutical Industries Ltd.; Sanofi SA; Taiwan Liposome Company Ltd.; GE Healthcare Technologies Inc.; Mallinckrodt plc; Leadiant Biosciences; Luminex Corporation; Bristol-Myers Squibb Company; CytImmune Sciences Inc.; Nanobiotix; Starpharma Holdings Limited; Copernicus Therapeutics Inc.; NanoCarrier Co. Ltd; Ensysce Biosciences Inc.; Ocuphire Pharma Inc.; LiPlasome Pharma ApS; Nami Therapeutics Corp.; Nanospectra Biosciences Inc.; Genetic Immunity Inc.; Spago Nanomedical AB; Nanobiosym Inc.; Nanopoint Inc.; Nanosphere Health Sciences Inc.; Nanoviricides Inc.; Nanotherapeutics Inc.; Nanosyn Inc.; Nanoscale Corporation; Nanosys Inc.; Nanocarrier Co. Ltd.; Nanocor Therapeutics Inc.; Nanocyl SA; Nanogen Pvt. Ltd.
Get The Full Global Healthcare Nanotechnology Market Report
Healthcare Nanotechnology Market Overview
Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.
Healthcare Nanotechnology Global Market Report 2023 provides data on the global healthcare nanotechnology market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The healthcare nanotechnology market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.